Diltiazem Export Market Intelligence: India's 184 Suppliers Shipping to 71 Countries — TransData Nexus 2026

Q: Who are the top diltiazem exporters from India?

The top diltiazem exporters from India are: 1. EMCURE PHARMACEUTICALS LIMITED — $3.2M (18.0% market share); 2. MAIVA PHARMA PRIVATE LIMITED — $2.3M (12.9% market share); 3. PIRAMAL PHARMA LIMITED — $2.1M (11.4% market share); 4. INTAS PHARMACEUTICALS LIMITED — $1.8M (9.8% market share); 5. MYLAN LABORATORIES LIMITED — $1.2M (6.9% market share). Together they account for 59.0% of India's total diltiazem export value.

Q: What is the total export value of diltiazem from India?

The total export value of diltiazem from India is $18.0M USD, recorded across 1,820 shipment transactions from 184 active exporters to 71 destination countries. The average shipment value is $9.9K.

Q: Which countries import diltiazem from India?

India exports diltiazem to 71 countries worldwide. The top importing countries are: UNITED STATES (62.4% share, $11.2M), CANADA (18.8% share, $3.4M), SRI LANKA (8.8% share, $1.6M), UNITED ARAB EMIRATES (3.1% share, $555.9K), MYANMAR (1.5% share, $272.3K). These five markets account for 94.6% of total export value.

Q: What is the HS code for diltiazem exports from India?

The primary HS code for diltiazem exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of diltiazem exports from India?

The average unit price for diltiazem exports from India is $137.02 USD per unit, with prices ranging from $0.00 to $39947.18 depending on formulation, packaging, and order volume. The total market is valued at $18.0M across 1,820 shipments.

Q: Which ports handle diltiazem exports from India?

The primary ports for diltiazem exports from India are SAHAR AIR (19.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (16.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (11.0% of shipments), NHAVA SHEVA SEA (INNSA1) (9.9% of shipments), DELHI AIR (8.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of diltiazem?

India is one of the world's leading exporters of diltiazem due to its large base of 184 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports diltiazem to 71 countries, demonstrating 36% global market coverage.

Q: What certifications do Indian diltiazem exporters need?

Indian diltiazem exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import diltiazem from India?

There are 298 registered buyers importing diltiazem from India, spread across 71 countries. The repeat buyer rate is 60.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top diltiazem supplier from India?

EMCURE PHARMACEUTICALS LIMITED is the leading diltiazem exporter from India with a market share of 18.0% and total export value of $3.2M across 130 shipments. The top 5 suppliers together control 59.0% of total export value.

Suresh Sormare

Diltiazem

India Pharmaceutical Trade Intelligence

$18.0M184 Suppliers71 CountriesHS 30049079

ExportsIndia → UNITED STATES62.4%India → CANADA18.8%

ImportsUNITED KINGDOM → India$760.0K UNITED STATES → India$155.5K

#1 Supplier: EMCURE PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Diltiazem Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Diltiazem to the World

Between 2022 and 2026, India exported $18.0M worth of diltiazem across 1,820 verified shipments to 71 countries — covering 36% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (62.4%). EMCURE PHARMACEUTICALS LIMITED leads with a 18.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Diltiazem export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Diltiazem export data snapshot — $18.0M · 184 exporters · 71 countriesTransData Nexus · Indian Customs Data

Top Diltiazem Exporters from India

184 active exporters · Ranked by export value

View all 184 →

Top Diltiazem Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	EMCURE PHARMACEUTICALS LIMITED	$3.2M	130	3	18.0%
2	MAIVA PHARMA PRIVATE LIMITED

Top Countries Importing Diltiazem from India

71 destination markets · Ranked by import value

All 71 countries →

Top Countries Importing Diltiazem from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$11.2M	62.4%
2	CANADA	$3.4M	18.8%
3	SRI LANKA	$1.6M	8.8%
4	UNITED ARAB EMIRATES	$555.9K	3.1%
5	MYANMAR	$272.3K	1.5%
6	SPAIN	$249.0K	1.4%
7	MAURITIUS	$90.8K	0.5%
8	UNITED KINGDOM	$82.0K	0.5%
9	ECUADOR	$77.1K	0.4%
10	PHILIPPINES	$56.8K	0.3%

UNITED STATES is India's largest diltiazem export destination, absorbing 62.4% of total exports worth $11.2M. The top 5 importing countries — UNITED STATES, CANADA, SRI LANKA, UNITED ARAB EMIRATES, MYANMAR — together account for 94.6% of India's total diltiazem export value. The remaining 66 destination countries collectively receive the other 5.4%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Diltiazem to India?

5 origin countries · Total import value: $947.4K

India imports diltiazem from 5 countries with a combined import value of $947.4K. The largest supplier is UNITED KINGDOM ($760.0K, 3 shipments), followed by UNITED STATES and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Diltiazem to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED KINGDOM	$760.0K	3	80.2%
2	UNITED STATES	$155.5K	112	16.4%
3	CANADA	$30.8K	10	3.3%
4	CHINA	$1.0K	11	0.1%
5	GERMANY	$34	6	0.0%

UNITED KINGDOM is the largest supplier of diltiazem to India, accounting for 80.2% of total import value. The top 5 origin countries — UNITED KINGDOM, UNITED STATES, CANADA, CHINA, GERMANY — together supply 100.0% of India's diltiazem imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Diltiazem

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, diltiazem is approved under multiple Abbreviated New Drug Applications (ANDAs). For instance, Mylan Pharmaceuticals received approval for diltiazem hydrochloride extended-release capsules (ANDA 75-124) on March 18, 1998. Additionally, Zydus Pharmaceuticals (USA) Inc. was granted approval for Tiadylt ER (diltiazem hydrochloride extended-release capsules) on June 22, 2017. These approvals indicate a well-established generic market for diltiazem in the U.S. The significant export volume from India to the U.S. underscores the importance of compliance with FDA regulations, including adherence to Current Good Manufacturing Practices (cGMP) and ensuring bioequivalence to the reference listed drug.

2EU & UK Regulatory Framework

In the European Union, diltiazem is authorized for marketing through national procedures. The European Medicines Agency (EMA) conducted a periodic safety update report single assessment (PSUSA) for diltiazem, resulting in a variation to the terms of the marketing authorization in March 2023. (ema.europa.eu) In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) has managed the licensing of diltiazem products, with records indicating approvals dating back to May 9, 1994. (gov.uk) Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturers exporting to these markets.

3WHO Essential Medicines & Global Standards

Diltiazem is included in the World Health Organization's Model List of Essential Medicines, highlighting its importance in global health. The drug is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, diltiazem is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including diltiazem, to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for diltiazem have expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, including Indian exporters, into global markets.

6Recent Industry Developments

In March 2023, the EMA issued a variation to the marketing authorization for diltiazem following a periodic safety update report assessment. (ema.europa.eu) In April 2022, the MHRA released information regarding the licensing history and status of diltiazem products in the UK. (gov.uk) These developments underscore the dynamic regulatory environment surrounding diltiazem, necessitating continuous monitoring by exporters to ensure compliance with international standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Diltiazem

Retail & reference prices across 9 markets vs. India FOB export price of $137.02/unit

Global Price Benchmark for Diltiazem across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$20–$25	USD	According to DrugPatentWatch, as of December 2025, the average monthly cost for generic diltiazem 180 mg extended-release tablets in the U.S. is approximately $20–$25, while branded versions range from $150–$200.
United Kingdom	$6.50–$13	GBP	The UK's National Health Service (NHS) Drug Tariff lists generic diltiazem 180 mg extended-release tablets at approximately £5–£10 per month.
Germany	$11–$16.50	EUR	The German Federal Joint Committee (G-BA) sets reference prices for medications, with generic diltiazem 180 mg extended-release tablets priced at approximately €10–€15 per month.

Supply Chain Risk Assessment — Diltiazem

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Diltiazem, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from China, underscoring a significant dependency. This reliance exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and production disruptions in China.

In October 2025, the U.S. Pharmacopeia highlighted that 58% of KSMs used for U.S.-approved APIs are solely sourced from a single country, predominantly China. Such concentration increases vulnerability to supply chain disruptions, which can lead to shortages and impact global pharmaceutical manufacturing, including India's Diltiazem production.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of Diltiazem account for 59.0% of total exports, with EMCURE PHARMACEUTICALS LIMITED leading at an 18.0% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global Diltiazem availability.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic API and KSM production. While this initiative is a positive step toward reducing dependency on imports, its full impact on diversifying the supplier base and enhancing supply chain resilience remains to be seen.

Access Complete Diltiazem Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,820 transactions across 71 markets.

Request Demo View Pricing

Frequently Asked Questions — Diltiazem Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top diltiazem exporters from India?

The leading diltiazem exporters from India are EMCURE PHARMACEUTICALS LIMITED, MAIVA PHARMA PRIVATE LIMITED, PIRAMAL PHARMA LIMITED, and 11 others. EMCURE PHARMACEUTICALS LIMITED leads with 18.0% market share ($3.2M). The top 5 suppliers together control 59.0% of total export value.

What is the total export value of diltiazem from India?

The total export value of diltiazem from India is $18.0M, recorded across 1,820 shipments from 184 active exporters to 71 countries. The average shipment value is $9.9K.

Which countries import diltiazem from India?

India exports diltiazem to 71 countries. The top importing countries are UNITED STATES (62.4%), CANADA (18.8%), SRI LANKA (8.8%), UNITED ARAB EMIRATES (3.1%), MYANMAR (1.5%), which together account for 94.6% of total export value.

What is the HS code for diltiazem exports from India?

The primary HS code for diltiazem exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Diltiazem

Diltiazem

Top Diltiazem Exporters from India

Top Countries Importing Diltiazem from India

Who Supplies Diltiazem to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Diltiazem

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Diltiazem

Supply Chain Risk Assessment — Diltiazem

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Diltiazem Trade Intelligence

Frequently Asked Questions — Diltiazem Exports from India

Who are the top diltiazem exporters from India?

What is the total export value of diltiazem from India?

Which countries import diltiazem from India?

What is the HS code for diltiazem exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of diltiazem exports from India?

Which ports handle diltiazem exports from India?

Why is India a leading exporter of diltiazem?

What certifications do Indian diltiazem exporters need?

How many buyers import diltiazem from India?

What is the market share of the top diltiazem exporter from India?

Analysis Methodology